RxDoctor Payments Data

Teri Longacre, MD

Anatomic Pathology & Clinical Pathology · Stanford, CANPI 1528120896

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $57,160 of the $60,166 with a category attached, or 95.0%. Astellas Pharma Europe Ltd accounts for 64.4% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $42,190, 3.2 times the $13,250 reported in 2019. Among anatomic pathology & clinical pathology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$60,166in general payments, 2019–2025

Across 24 payments — averaging $2506.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma Europe Ltd$39K
  • Astellas Pharma US Inc$8K
  • Merck$7K
  • Verastem, Inc.$3K
  • AstraZeneca$2K
  • Blueprint Medicines Corporation$1K
  • plus $112 from 2 others

What the payments were for

  • Consulting fees$57,16095%
  • Speaking & faculty fees$1,2452%
  • Travel & lodging$1,3382%
  • Food & beverage$4231%

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$60,166 in reported general payments places this provider in the 95th percentile of 814 anatomic pathology & clinical pathology providers in California.

See all anatomic pathology & clinical pathology providers in California

Medicare billing

Part B allowed, 2024
$116,862
Medicare patients
817
Services billed
2,411

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →